Fortress Biotech, Inc. - Net Worth and Insider Trading
Fortress Biotech, Inc. Net Worth
The estimated net worth of Fortress Biotech, Inc. is at least $28,356 dollars as of 2024-11-29. Fortress Biotech, Inc. is the 10% Owner of Avenue Therapeutics Inc and owns about 13,765 shares of Avenue Therapeutics Inc (ATXI) stock worth over $28,356. Details can be seen in Fortress Biotech, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fortress Biotech, Inc. has not made any transactions after 2023-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fortress Biotech, Inc.
Fortress Biotech, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fortress Biotech, Inc. owns 5 companies in total, including Checkpoint Therapeutics Inc (CKPT) , Avenue Therapeutics Inc (ATXI) , and Mustang Bio Inc (MBIO) among others .
Click here to see the complete history of Fortress Biotech, Inc.’s form 4 insider trades.
Insider Ownership Summary of Fortress Biotech, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CKPT | Checkpoint Therapeutics Inc | 2023-01-05 | 10 percent owner |
| ATXI | Avenue Therapeutics Inc | 2023-09-08 | 10 percent owner |
| MBIO | Mustang Bio Inc | 2023-01-06 | 10 percent owner |
 | | 2016-09-12 | 10 percent owner |
| | 2016-05-20 | 10 percent owner |
Fortress Biotech, Inc. Latest Holdings Summary
Fortress Biotech, Inc. currently owns a total of 1 stock. Fortress Biotech, Inc. owns 13,765 shares of Avenue Therapeutics Inc (ATXI) as of September 8, 2023, with a value of $28,356.
Latest Holdings of Fortress Biotech, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2023-09-08 | 13,765 | 2.06 | 28,356 |
Holding Weightings of Fortress Biotech, Inc.
Fortress Biotech, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Fortress Biotech, Inc. has made a total of 1 transactions in Avenue Therapeutics Inc (ATXI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Avenue Therapeutics Inc is the acquisition of 5,579 shares on September 8, 2023, which cost Fortress Biotech, Inc. around $301,255.
Insider Trading History of Fortress Biotech, Inc.
- 1
Fortress Biotech, Inc. Trading Performance
GuruFocus tracks the stock performance after each of Fortress Biotech, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fortress Biotech, Inc. is -79.53%. GuruFocus also compares Fortress Biotech, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Fortress Biotech, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fortress Biotech, Inc.'s insider trading performs compared to the benchmark.
Performance of Fortress Biotech, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.71 | | | | | |
| Relative Return to S&P 500(%) | -14.37 | | | | | |
Fortress Biotech, Inc. Ownership Network
Fortress Biotech, Inc. Owned Company Details
What does Checkpoint Therapeutics Inc do?
Who are the key executives at Checkpoint Therapeutics Inc?
Fortress Biotech, Inc. is the 10 percent owner of Checkpoint Therapeutics Inc. Other key executives at Checkpoint Therapeutics Inc include See Remarks William Garrett Gray , director & CEO & President and Director Oliviero James F Iii , and Interim CFO David J Horin .
Checkpoint Therapeutics Inc (CKPT) Insider Trades Summary
Over the past 18 months, Fortress Biotech, Inc. made no insider transaction in Checkpoint Therapeutics Inc (CKPT). Other recent insider transactions involving Checkpoint Therapeutics Inc (CKPT) include a net sale of 42,404 shares made by Oliviero James F Iii , and a net sale of 19,188 shares made by William Garrett Gray .
In summary, during the past 3 months, insiders sold 0 shares of Checkpoint Therapeutics Inc (CKPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,592 shares of Checkpoint Therapeutics Inc (CKPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,592 shares.
Checkpoint Therapeutics Inc (CKPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkpoint Therapeutics Inc Insider Transactions
Fortress Biotech, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Fortress Biotech, Inc.. You might contact Fortress Biotech, Inc. via mailing address: 1111 Kane Concourse, Suite 301, Bay Harbor Islands Fl 33154.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
